Vitamin Shoppe, Inc (NYSE:VSI) is set to release its earnings data before the market opens on Wednesday, August 9th. Analysts expect Vitamin Shoppe to post earnings of $0.40 per share for the quarter. Vitamin Shoppe has set its FY17 guidance at $1.50-1.75 EPS.

Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings data on Wednesday, May 10th. The specialty retailer reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.58 by $0.21. Vitamin Shoppe had a return on equity of 9.35% and a net margin of 1.43%. The company had revenue of $316.90 million for the quarter, compared to the consensus estimate of $325.71 million. During the same quarter in the previous year, the firm posted $0.67 EPS. The business’s revenue for the quarter was down 5.9% compared to the same quarter last year. On average, analysts expect Vitamin Shoppe to post $1.57 EPS for the current fiscal year and $1.68 EPS for the next fiscal year.

Vitamin Shoppe, Inc (NYSE:VSI) opened at 9.85 on Tuesday. The company has a market cap of $228.16 million, a P/E ratio of 12.68 and a beta of 0.68. The stock’s 50 day moving average is $11.06 and its 200 day moving average is $16.58. Vitamin Shoppe, Inc has a 12-month low of $9.75 and a 12-month high of $28.94.

A number of research firms have recently issued reports on VSI. Morgan Stanley upgraded shares of Vitamin Shoppe from an “underweight” rating to an “equal weight” rating and set a $14.00 target price for the company in a research note on Thursday, May 11th. Gabelli lowered shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Thursday, May 11th. ValuEngine lowered shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. BidaskClub lowered shares of Vitamin Shoppe from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Finally, Zacks Investment Research lowered shares of Vitamin Shoppe from a “hold” rating to a “strong sell” rating in a research report on Saturday, May 13th. Two research analysts have rated the stock with a sell rating and seven have given a hold rating to the company. The stock currently has an average rating of “Hold” and an average price target of $21.50.

COPYRIGHT VIOLATION NOTICE: This news story was first reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another site, it was copied illegally and reposted in violation of US and international trademark and copyright law. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/08/08/vitamin-shoppe-inc-vsi-scheduled-to-post-earnings-on-wednesday.html.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Earnings History for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.